As assisted reproduction becomes commonplace, medical and moral difficulties remain.
A civilian adviser says private enterprise is the key to Afghan reconstruction.
The American household is better off than you think.
Government spending, not tax revenue, is a better measure of public involvement in private markets.
A maturing industry faces an aging user base.
Japan continues to grow, defying the expectations of pessimists and triumphalists alike.
The developed nations are happy to send aid, but reluctant to ask uncomfortable questions.
A new weekly feature.
Most international agencies have broken down in their efforts to help the country. FIFA can do better.
A sad litany of new examples suggests the FDA has lost its ability to reason about risk.
One way or another, investment managers are always accountable to their clients.
A U.S. initiative encourages businesses to see Africa’s poor as an untapped market.
Weight has always been hard to control, says a leading science writer.
Unless the public intervenes, a new rule will make patients sicker.
How the U.S. uses trade agreements to promote democracy
Making it cheaper to drive a mile won’t help the environment.
Nearly two years later, how goes the fight for eminent domain reform?
Paris Hilton, electronic spam, political loyalties and more...
Yesterday’s theatrics over stem cell funding overshadowed the real news: Scientists are finding ethical, alternative ways to get the same work done.
Last year’s ban on internet gambling marked a major setback for the industry, but Congress is taking a second look at the issue… and things might be changing in any case.